Roche sales, stock hit by Tamiflu slump
(Reuters)
<p><img src="http://d.yimg.com/us.yimg.com/p/afp/20080417/capt.cps.mxv66.170408093017.photo00.photo.default-512x341.jpg?x=130&y=86&q=85&sig=lDDG6j0AtHf4moUu9Vu4lg--" align="left" height="86" width="130" alt="A logo of the Swiss pharmaceuticals giant Roche is seen on a building in Basel, in 2007. Roche said Thursday its first quarter sales fell four percent on a Swiss franc basis due to a drop in its key flu drug Tamiflu.(AFP/File/Fabrice Coffrini)" border="0" /> (http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20080417/bs_nm/roche_dc)Reuters - Roche Holding AG missed
forecasts with a meager 2 percent increase in first-quarter
sales in local currencies, hit by plunging Tamiflu revenue and
a slowing pace of growth for cancer drugs.</p><br clear="all"/>
http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20080417/bs_nm/roche_dc